Legal Representation
Attorney
                                            Steven C. Sereboff
                                        USPTO Deadlines
                                Next Deadline
                            
                            
                                    
                                        
                                        71 days remaining
                                    
                            
                        Statement of Use Due - Extension 1 Granted
                                    
                                    Due Date
                                
                                
                                    January 14, 2026
                                
                            
                                        
                                        Extension Available
                                    
                                    
                                        Until January 14, 2026
                                    
                                Application History
24 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Sep 9, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... | 
| Sep 9, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... | 
| Sep 9, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... | 
| Sep 9, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... | 
| Jun 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... | 
| Jun 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... | 
| Jun 24, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... | 
| Jun 24, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... | 
| Jan 14, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... | 
| Dec 18, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... | 
| Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... | 
| Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... | 
| Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... | 
| Oct 16, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... | 
| Oct 16, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Oct 16, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Oct 16, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Oct 16, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... | 
| Oct 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Oct 16, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Oct 16, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Oct 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Mar 29, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Mar 29, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 005
                                            
                                        Vitamins; Dietary and nutritional supplements
                                        Classification
                                            
                                            International Classes
                                        
                                        
                                                    005
                                            
                                        Disclaimers
                                    
                                    The following terms have been disclaimed and are not claimed as part of the trademark:
                                
                                    
                                                Specific Disclaimer
                                        
                                        
                                            "MD"